Global Glioma Treatment Supply, Demand and Key Producers, 2023-2029
Page: 130
Published Date: 06 Sep 2023
Category: Pharma & Healthcare
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
The global Glioma Treatment market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Chemotherapy is usually used in combination with radiation therapy to treat gliomas. The chemotherapy drug used most often to treat gliomas is temozolomide (Temodar), which is taken as a pill. Side effects of chemotherapy depend on the type and dose of drugs you receive.
This report studies the global Glioma Treatment production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Glioma Treatment, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Glioma Treatment that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Glioma Treatment total production and demand, 2018-2029, (K Units)
Global Glioma Treatment total production value, 2018-2029, (USD Million)
Global Glioma Treatment production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Glioma Treatment consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Glioma Treatment domestic production, consumption, key domestic manufacturers and share
Global Glioma Treatment production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Glioma Treatment production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Glioma Treatment production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units).
This reports profiles key players in the global Glioma Treatment market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sun Pharmaceutical, Amgen, Teva Pharmaceutical, Bristol-Myers Squibb, Pfizer, Merck, Eli Lilly, F. Hoffmann-La Roche Ltd and AbbVie, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Glioma Treatment market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Glioma Treatment Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global Glioma Treatment Market, Segmentation by Type
ChemOthersapy
Drugs
Global Glioma Treatment Market, Segmentation by Application
Hospitals
Cancer Research Organizations
Diagnostic Centers
Others
Companies Profiled:
Sun Pharmaceutical
Amgen
Teva Pharmaceutical
Bristol-Myers Squibb
Pfizer
Merck
Eli Lilly
F. Hoffmann-La Roche Ltd
AbbVie
Genentech
BioMimetix
Cipla
Sigma-Aldrich
Panacea Biotec
Zydus Cadila
Takeda Pharmaceuticals
Boston Biomedical
Ziopharm Oncology
Celldex Therapeutics
BERG
Oncorus
Agenus
Deciphera Pharmaceuticals
Karyopharm Therapeutics
Key Questions Answered
1. How big is the global Glioma Treatment market?
2. What is the demand of the global Glioma Treatment market?
3. What is the year over year growth of the global Glioma Treatment market?
4. What is the production and production value of the global Glioma Treatment market?
5. Who are the key producers in the global Glioma Treatment market?
Table of Contents
1 Supply Summary
1.1 Glioma Treatment Introduction
1.2 World Glioma Treatment Supply & Forecast
1.2.1 World Glioma Treatment Production Value (2018 & 2022 & 2029)
1.2.2 World Glioma Treatment Production (2018-2029)
1.2.3 World Glioma Treatment Pricing Trends (2018-2029)
1.3 World Glioma Treatment Production by Region (Based on Production Site)
1.3.1 World Glioma Treatment Production Value by Region (2018-2029)
1.3.2 World Glioma Treatment Production by Region (2018-2029)
1.3.3 World Glioma Treatment Average Price by Region (2018-2029)
1.3.4 North America Glioma Treatment Production (2018-2029)
1.3.5 Europe Glioma Treatment Production (2018-2029)
1.3.6 China Glioma Treatment Production (2018-2029)
1.3.7 Japan Glioma Treatment Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Glioma Treatment Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Glioma Treatment Major Market Trends
2.1 World Glioma Treatment Demand (2018-2029)
2.2 World Glioma Treatment Consumption by Region
2.2.1 World Glioma Treatment Consumption by Region (2018-2023)
2.2.2 World Glioma Treatment Consumption Forecast by Region (2024-2029)
2.3 United States Glioma Treatment Consumption (2018-2029)
2.4 China Glioma Treatment Consumption (2018-2029)
2.5 Europe Glioma Treatment Consumption (2018-2029)
2.6 Japan Glioma Treatment Consumption (2018-2029)
2.7 South Korea Glioma Treatment Consumption (2018-2029)
2.8 ASEAN Glioma Treatment Consumption (2018-2029)
2.9 India Glioma Treatment Consumption (2018-2029)
3.1 World Glioma Treatment Production Value by Manufacturer (2018-2023)
3.2 World Glioma Treatment Production by Manufacturer (2018-2023)
3.3 World Glioma Treatment Average Price by Manufacturer (2018-2023)
3.4 Glioma Treatment Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Glioma Treatment Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Glioma Treatment in 2022
3.5.3 Global Concentration Ratios (CR8) for Glioma Treatment in 2022
3.6 Glioma Treatment Market: Overall Company Footprint Analysis
3.6.1 Glioma Treatment Market: Region Footprint
3.6.2 Glioma Treatment Market: Company Product Type Footprint
3.6.3 Glioma Treatment Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4.1 United States VS China: Glioma Treatment Production Value Comparison
4.1.1 United States VS China: Glioma Treatment Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Glioma Treatment Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Glioma Treatment Production Comparison
4.2.1 United States VS China: Glioma Treatment Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Glioma Treatment Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Glioma Treatment Consumption Comparison
4.3.1 United States VS China: Glioma Treatment Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Glioma Treatment Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Glioma Treatment Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Glioma Treatment Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Glioma Treatment Production Value (2018-2023)
4.4.3 United States Based Manufacturers Glioma Treatment Production (2018-2023)
4.5 China Based Glioma Treatment Manufacturers and Market Share
4.5.1 China Based Glioma Treatment Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Glioma Treatment Production Value (2018-2023)
4.5.3 China Based Manufacturers Glioma Treatment Production (2018-2023)
4.6 Rest of World Based Glioma Treatment Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Glioma Treatment Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Glioma Treatment Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Glioma Treatment Production (2018-2023)
5.1 World Glioma Treatment Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 ChemOthersapy
5.2.2 Drugs
5.3 Market Segment by Type
5.3.1 World Glioma Treatment Production by Type (2018-2029)
5.3.2 World Glioma Treatment Production Value by Type (2018-2029)
5.3.3 World Glioma Treatment Average Price by Type (2018-2029)
6.1 World Glioma Treatment Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospitals
6.2.2 Cancer Research Organizations
6.2.3 Diagnostic Centers
6.2.4 Others
6.3 Market Segment by Application
6.3.1 World Glioma Treatment Production by Application (2018-2029)
6.3.2 World Glioma Treatment Production Value by Application (2018-2029)
6.3.3 World Glioma Treatment Average Price by Application (2018-2029)
7.1 Sun Pharmaceutical
7.1.1 Sun Pharmaceutical Details
7.1.2 Sun Pharmaceutical Major Business
7.1.3 Sun Pharmaceutical Glioma Treatment Product and Services
7.1.4 Sun Pharmaceutical Glioma Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Sun Pharmaceutical Recent Developments/Updates
7.1.6 Sun Pharmaceutical Competitive Strengths & Weaknesses
7.2 Amgen
7.2.1 Amgen Details
7.2.2 Amgen Major Business
7.2.3 Amgen Glioma Treatment Product and Services
7.2.4 Amgen Glioma Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Amgen Recent Developments/Updates
7.2.6 Amgen Competitive Strengths & Weaknesses
7.3 Teva Pharmaceutical
7.3.1 Teva Pharmaceutical Details
7.3.2 Teva Pharmaceutical Major Business
7.3.3 Teva Pharmaceutical Glioma Treatment Product and Services
7.3.4 Teva Pharmaceutical Glioma Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Teva Pharmaceutical Recent Developments/Updates
7.3.6 Teva Pharmaceutical Competitive Strengths & Weaknesses
7.4 Bristol-Myers Squibb
7.4.1 Bristol-Myers Squibb Details
7.4.2 Bristol-Myers Squibb Major Business
7.4.3 Bristol-Myers Squibb Glioma Treatment Product and Services
7.4.4 Bristol-Myers Squibb Glioma Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Bristol-Myers Squibb Recent Developments/Updates
7.4.6 Bristol-Myers Squibb Competitive Strengths & Weaknesses
7.5 Pfizer
7.5.1 Pfizer Details
7.5.2 Pfizer Major Business
7.5.3 Pfizer Glioma Treatment Product and Services
7.5.4 Pfizer Glioma Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Pfizer Recent Developments/Updates
7.5.6 Pfizer Competitive Strengths & Weaknesses
7.6 Merck
7.6.1 Merck Details
7.6.2 Merck Major Business
7.6.3 Merck Glioma Treatment Product and Services
7.6.4 Merck Glioma Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Merck Recent Developments/Updates
7.6.6 Merck Competitive Strengths & Weaknesses
7.7 Eli Lilly
7.7.1 Eli Lilly Details
7.7.2 Eli Lilly Major Business
7.7.3 Eli Lilly Glioma Treatment Product and Services
7.7.4 Eli Lilly Glioma Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Eli Lilly Recent Developments/Updates
7.7.6 Eli Lilly Competitive Strengths & Weaknesses
7.8 F. Hoffmann-La Roche Ltd
7.8.1 F. Hoffmann-La Roche Ltd Details
7.8.2 F. Hoffmann-La Roche Ltd Major Business
7.8.3 F. Hoffmann-La Roche Ltd Glioma Treatment Product and Services
7.8.4 F. Hoffmann-La Roche Ltd Glioma Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 F. Hoffmann-La Roche Ltd Recent Developments/Updates
7.8.6 F. Hoffmann-La Roche Ltd Competitive Strengths & Weaknesses
7.9 AbbVie
7.9.1 AbbVie Details
7.9.2 AbbVie Major Business
7.9.3 AbbVie Glioma Treatment Product and Services
7.9.4 AbbVie Glioma Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 AbbVie Recent Developments/Updates
7.9.6 AbbVie Competitive Strengths & Weaknesses
7.10 Genentech
7.10.1 Genentech Details
7.10.2 Genentech Major Business
7.10.3 Genentech Glioma Treatment Product and Services
7.10.4 Genentech Glioma Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Genentech Recent Developments/Updates
7.10.6 Genentech Competitive Strengths & Weaknesses
7.11 BioMimetix
7.11.1 BioMimetix Details
7.11.2 BioMimetix Major Business
7.11.3 BioMimetix Glioma Treatment Product and Services
7.11.4 BioMimetix Glioma Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 BioMimetix Recent Developments/Updates
7.11.6 BioMimetix Competitive Strengths & Weaknesses
7.12 Cipla
7.12.1 Cipla Details
7.12.2 Cipla Major Business
7.12.3 Cipla Glioma Treatment Product and Services
7.12.4 Cipla Glioma Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 Cipla Recent Developments/Updates
7.12.6 Cipla Competitive Strengths & Weaknesses
7.13 Sigma-Aldrich
7.13.1 Sigma-Aldrich Details
7.13.2 Sigma-Aldrich Major Business
7.13.3 Sigma-Aldrich Glioma Treatment Product and Services
7.13.4 Sigma-Aldrich Glioma Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 Sigma-Aldrich Recent Developments/Updates
7.13.6 Sigma-Aldrich Competitive Strengths & Weaknesses
7.14 Panacea Biotec
7.14.1 Panacea Biotec Details
7.14.2 Panacea Biotec Major Business
7.14.3 Panacea Biotec Glioma Treatment Product and Services
7.14.4 Panacea Biotec Glioma Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 Panacea Biotec Recent Developments/Updates
7.14.6 Panacea Biotec Competitive Strengths & Weaknesses
7.15 Zydus Cadila
7.15.1 Zydus Cadila Details
7.15.2 Zydus Cadila Major Business
7.15.3 Zydus Cadila Glioma Treatment Product and Services
7.15.4 Zydus Cadila Glioma Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.15.5 Zydus Cadila Recent Developments/Updates
7.15.6 Zydus Cadila Competitive Strengths & Weaknesses
7.16 Takeda Pharmaceuticals
7.16.1 Takeda Pharmaceuticals Details
7.16.2 Takeda Pharmaceuticals Major Business
7.16.3 Takeda Pharmaceuticals Glioma Treatment Product and Services
7.16.4 Takeda Pharmaceuticals Glioma Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.16.5 Takeda Pharmaceuticals Recent Developments/Updates
7.16.6 Takeda Pharmaceuticals Competitive Strengths & Weaknesses
7.17 Boston Biomedical
7.17.1 Boston Biomedical Details
7.17.2 Boston Biomedical Major Business
7.17.3 Boston Biomedical Glioma Treatment Product and Services
7.17.4 Boston Biomedical Glioma Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.17.5 Boston Biomedical Recent Developments/Updates
7.17.6 Boston Biomedical Competitive Strengths & Weaknesses
7.18 Ziopharm Oncology
7.18.1 Ziopharm Oncology Details
7.18.2 Ziopharm Oncology Major Business
7.18.3 Ziopharm Oncology Glioma Treatment Product and Services
7.18.4 Ziopharm Oncology Glioma Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.18.5 Ziopharm Oncology Recent Developments/Updates
7.18.6 Ziopharm Oncology Competitive Strengths & Weaknesses
7.19 Celldex Therapeutics
7.19.1 Celldex Therapeutics Details
7.19.2 Celldex Therapeutics Major Business
7.19.3 Celldex Therapeutics Glioma Treatment Product and Services
7.19.4 Celldex Therapeutics Glioma Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.19.5 Celldex Therapeutics Recent Developments/Updates
7.19.6 Celldex Therapeutics Competitive Strengths & Weaknesses
7.20 BERG
7.20.1 BERG Details
7.20.2 BERG Major Business
7.20.3 BERG Glioma Treatment Product and Services
7.20.4 BERG Glioma Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.20.5 BERG Recent Developments/Updates
7.20.6 BERG Competitive Strengths & Weaknesses
7.21 Oncorus
7.21.1 Oncorus Details
7.21.2 Oncorus Major Business
7.21.3 Oncorus Glioma Treatment Product and Services
7.21.4 Oncorus Glioma Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.21.5 Oncorus Recent Developments/Updates
7.21.6 Oncorus Competitive Strengths & Weaknesses
7.22 Agenus
7.22.1 Agenus Details
7.22.2 Agenus Major Business
7.22.3 Agenus Glioma Treatment Product and Services
7.22.4 Agenus Glioma Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.22.5 Agenus Recent Developments/Updates
7.22.6 Agenus Competitive Strengths & Weaknesses
7.23 Deciphera Pharmaceuticals
7.23.1 Deciphera Pharmaceuticals Details
7.23.2 Deciphera Pharmaceuticals Major Business
7.23.3 Deciphera Pharmaceuticals Glioma Treatment Product and Services
7.23.4 Deciphera Pharmaceuticals Glioma Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.23.5 Deciphera Pharmaceuticals Recent Developments/Updates
7.23.6 Deciphera Pharmaceuticals Competitive Strengths & Weaknesses
7.24 Karyopharm Therapeutics
7.24.1 Karyopharm Therapeutics Details
7.24.2 Karyopharm Therapeutics Major Business
7.24.3 Karyopharm Therapeutics Glioma Treatment Product and Services
7.24.4 Karyopharm Therapeutics Glioma Treatment Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.24.5 Karyopharm Therapeutics Recent Developments/Updates
7.24.6 Karyopharm Therapeutics Competitive Strengths & Weaknesses
8.1 Glioma Treatment Industry Chain
8.2 Glioma Treatment Upstream Analysis
8.2.1 Glioma Treatment Core Raw Materials
8.2.2 Main Manufacturers of Glioma Treatment Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Glioma Treatment Production Mode
8.6 Glioma Treatment Procurement Model
8.7 Glioma Treatment Industry Sales Model and Sales Channels
8.7.1 Glioma Treatment Sales Model
8.7.2 Glioma Treatment Typical Customers
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
Table of Figures
List of Tables
Table 1. World Glioma Treatment Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Glioma Treatment Production Value by Region (2018-2023) & (USD Million)
Table 3. World Glioma Treatment Production Value by Region (2024-2029) & (USD Million)
Table 4. World Glioma Treatment Production Value Market Share by Region (2018-2023)
Table 5. World Glioma Treatment Production Value Market Share by Region (2024-2029)
Table 6. World Glioma Treatment Production by Region (2018-2023) & (K Units)
Table 7. World Glioma Treatment Production by Region (2024-2029) & (K Units)
Table 8. World Glioma Treatment Production Market Share by Region (2018-2023)
Table 9. World Glioma Treatment Production Market Share by Region (2024-2029)
Table 10. World Glioma Treatment Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Glioma Treatment Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Glioma Treatment Major Market Trends
Table 13. World Glioma Treatment Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Glioma Treatment Consumption by Region (2018-2023) & (K Units)
Table 15. World Glioma Treatment Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Glioma Treatment Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Glioma Treatment Producers in 2022
Table 18. World Glioma Treatment Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Glioma Treatment Producers in 2022
Table 20. World Glioma Treatment Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Glioma Treatment Company Evaluation Quadrant
Table 22. World Glioma Treatment Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Glioma Treatment Production Site of Key Manufacturer
Table 24. Glioma Treatment Market: Company Product Type Footprint
Table 25. Glioma Treatment Market: Company Product Application Footprint
Table 26. Glioma Treatment Competitive Factors
Table 27. Glioma Treatment New Entrant and Capacity Expansion Plans
Table 28. Glioma Treatment Mergers & Acquisitions Activity
Table 29. United States VS China Glioma Treatment Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Glioma Treatment Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Glioma Treatment Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Glioma Treatment Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Glioma Treatment Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Glioma Treatment Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Glioma Treatment Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Glioma Treatment Production Market Share (2018-2023)
Table 37. China Based Glioma Treatment Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Glioma Treatment Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Glioma Treatment Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Glioma Treatment Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Glioma Treatment Production Market Share (2018-2023)
Table 42. Rest of World Based Glioma Treatment Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Glioma Treatment Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Glioma Treatment Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Glioma Treatment Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Glioma Treatment Production Market Share (2018-2023)
Table 47. World Glioma Treatment Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Glioma Treatment Production by Type (2018-2023) & (K Units)
Table 49. World Glioma Treatment Production by Type (2024-2029) & (K Units)
Table 50. World Glioma Treatment Production Value by Type (2018-2023) & (USD Million)
Table 51. World Glioma Treatment Production Value by Type (2024-2029) & (USD Million)
Table 52. World Glioma Treatment Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Glioma Treatment Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Glioma Treatment Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Glioma Treatment Production by Application (2018-2023) & (K Units)
Table 56. World Glioma Treatment Production by Application (2024-2029) & (K Units)
Table 57. World Glioma Treatment Production Value by Application (2018-2023) & (USD Million)
Table 58. World Glioma Treatment Production Value by Application (2024-2029) & (USD Million)
Table 59. World Glioma Treatment Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Glioma Treatment Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Sun Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 62. Sun Pharmaceutical Major Business
Table 63. Sun Pharmaceutical Glioma Treatment Product and Services
Table 64. Sun Pharmaceutical Glioma Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Sun Pharmaceutical Recent Developments/Updates
Table 66. Sun Pharmaceutical Competitive Strengths & Weaknesses
Table 67. Amgen Basic Information, Manufacturing Base and Competitors
Table 68. Amgen Major Business
Table 69. Amgen Glioma Treatment Product and Services
Table 70. Amgen Glioma Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Amgen Recent Developments/Updates
Table 72. Amgen Competitive Strengths & Weaknesses
Table 73. Teva Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 74. Teva Pharmaceutical Major Business
Table 75. Teva Pharmaceutical Glioma Treatment Product and Services
Table 76. Teva Pharmaceutical Glioma Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Teva Pharmaceutical Recent Developments/Updates
Table 78. Teva Pharmaceutical Competitive Strengths & Weaknesses
Table 79. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 80. Bristol-Myers Squibb Major Business
Table 81. Bristol-Myers Squibb Glioma Treatment Product and Services
Table 82. Bristol-Myers Squibb Glioma Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Bristol-Myers Squibb Recent Developments/Updates
Table 84. Bristol-Myers Squibb Competitive Strengths & Weaknesses
Table 85. Pfizer Basic Information, Manufacturing Base and Competitors
Table 86. Pfizer Major Business
Table 87. Pfizer Glioma Treatment Product and Services
Table 88. Pfizer Glioma Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Pfizer Recent Developments/Updates
Table 90. Pfizer Competitive Strengths & Weaknesses
Table 91. Merck Basic Information, Manufacturing Base and Competitors
Table 92. Merck Major Business
Table 93. Merck Glioma Treatment Product and Services
Table 94. Merck Glioma Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Merck Recent Developments/Updates
Table 96. Merck Competitive Strengths & Weaknesses
Table 97. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 98. Eli Lilly Major Business
Table 99. Eli Lilly Glioma Treatment Product and Services
Table 100. Eli Lilly Glioma Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Eli Lilly Recent Developments/Updates
Table 102. Eli Lilly Competitive Strengths & Weaknesses
Table 103. F. Hoffmann-La Roche Ltd Basic Information, Manufacturing Base and Competitors
Table 104. F. Hoffmann-La Roche Ltd Major Business
Table 105. F. Hoffmann-La Roche Ltd Glioma Treatment Product and Services
Table 106. F. Hoffmann-La Roche Ltd Glioma Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. F. Hoffmann-La Roche Ltd Recent Developments/Updates
Table 108. F. Hoffmann-La Roche Ltd Competitive Strengths & Weaknesses
Table 109. AbbVie Basic Information, Manufacturing Base and Competitors
Table 110. AbbVie Major Business
Table 111. AbbVie Glioma Treatment Product and Services
Table 112. AbbVie Glioma Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. AbbVie Recent Developments/Updates
Table 114. AbbVie Competitive Strengths & Weaknesses
Table 115. Genentech Basic Information, Manufacturing Base and Competitors
Table 116. Genentech Major Business
Table 117. Genentech Glioma Treatment Product and Services
Table 118. Genentech Glioma Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Genentech Recent Developments/Updates
Table 120. Genentech Competitive Strengths & Weaknesses
Table 121. BioMimetix Basic Information, Manufacturing Base and Competitors
Table 122. BioMimetix Major Business
Table 123. BioMimetix Glioma Treatment Product and Services
Table 124. BioMimetix Glioma Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. BioMimetix Recent Developments/Updates
Table 126. BioMimetix Competitive Strengths & Weaknesses
Table 127. Cipla Basic Information, Manufacturing Base and Competitors
Table 128. Cipla Major Business
Table 129. Cipla Glioma Treatment Product and Services
Table 130. Cipla Glioma Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. Cipla Recent Developments/Updates
Table 132. Cipla Competitive Strengths & Weaknesses
Table 133. Sigma-Aldrich Basic Information, Manufacturing Base and Competitors
Table 134. Sigma-Aldrich Major Business
Table 135. Sigma-Aldrich Glioma Treatment Product and Services
Table 136. Sigma-Aldrich Glioma Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. Sigma-Aldrich Recent Developments/Updates
Table 138. Sigma-Aldrich Competitive Strengths & Weaknesses
Table 139. Panacea Biotec Basic Information, Manufacturing Base and Competitors
Table 140. Panacea Biotec Major Business
Table 141. Panacea Biotec Glioma Treatment Product and Services
Table 142. Panacea Biotec Glioma Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 143. Panacea Biotec Recent Developments/Updates
Table 144. Panacea Biotec Competitive Strengths & Weaknesses
Table 145. Zydus Cadila Basic Information, Manufacturing Base and Competitors
Table 146. Zydus Cadila Major Business
Table 147. Zydus Cadila Glioma Treatment Product and Services
Table 148. Zydus Cadila Glioma Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 149. Zydus Cadila Recent Developments/Updates
Table 150. Zydus Cadila Competitive Strengths & Weaknesses
Table 151. Takeda Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 152. Takeda Pharmaceuticals Major Business
Table 153. Takeda Pharmaceuticals Glioma Treatment Product and Services
Table 154. Takeda Pharmaceuticals Glioma Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 155. Takeda Pharmaceuticals Recent Developments/Updates
Table 156. Takeda Pharmaceuticals Competitive Strengths & Weaknesses
Table 157. Boston Biomedical Basic Information, Manufacturing Base and Competitors
Table 158. Boston Biomedical Major Business
Table 159. Boston Biomedical Glioma Treatment Product and Services
Table 160. Boston Biomedical Glioma Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 161. Boston Biomedical Recent Developments/Updates
Table 162. Boston Biomedical Competitive Strengths & Weaknesses
Table 163. Ziopharm Oncology Basic Information, Manufacturing Base and Competitors
Table 164. Ziopharm Oncology Major Business
Table 165. Ziopharm Oncology Glioma Treatment Product and Services
Table 166. Ziopharm Oncology Glioma Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 167. Ziopharm Oncology Recent Developments/Updates
Table 168. Ziopharm Oncology Competitive Strengths & Weaknesses
Table 169. Celldex Therapeutics Basic Information, Manufacturing Base and Competitors
Table 170. Celldex Therapeutics Major Business
Table 171. Celldex Therapeutics Glioma Treatment Product and Services
Table 172. Celldex Therapeutics Glioma Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 173. Celldex Therapeutics Recent Developments/Updates
Table 174. Celldex Therapeutics Competitive Strengths & Weaknesses
Table 175. BERG Basic Information, Manufacturing Base and Competitors
Table 176. BERG Major Business
Table 177. BERG Glioma Treatment Product and Services
Table 178. BERG Glioma Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 179. BERG Recent Developments/Updates
Table 180. BERG Competitive Strengths & Weaknesses
Table 181. Oncorus Basic Information, Manufacturing Base and Competitors
Table 182. Oncorus Major Business
Table 183. Oncorus Glioma Treatment Product and Services
Table 184. Oncorus Glioma Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 185. Oncorus Recent Developments/Updates
Table 186. Oncorus Competitive Strengths & Weaknesses
Table 187. Agenus Basic Information, Manufacturing Base and Competitors
Table 188. Agenus Major Business
Table 189. Agenus Glioma Treatment Product and Services
Table 190. Agenus Glioma Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 191. Agenus Recent Developments/Updates
Table 192. Agenus Competitive Strengths & Weaknesses
Table 193. Deciphera Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 194. Deciphera Pharmaceuticals Major Business
Table 195. Deciphera Pharmaceuticals Glioma Treatment Product and Services
Table 196. Deciphera Pharmaceuticals Glioma Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 197. Deciphera Pharmaceuticals Recent Developments/Updates
Table 198. Karyopharm Therapeutics Basic Information, Manufacturing Base and Competitors
Table 199. Karyopharm Therapeutics Major Business
Table 200. Karyopharm Therapeutics Glioma Treatment Product and Services
Table 201. Karyopharm Therapeutics Glioma Treatment Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 202. Global Key Players of Glioma Treatment Upstream (Raw Materials)
Table 203. Glioma Treatment Typical Customers
Table 204. Glioma Treatment Typical Distributors
List of Figure
Figure 1. Glioma Treatment Picture
Figure 2. World Glioma Treatment Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Glioma Treatment Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Glioma Treatment Production (2018-2029) & (K Units)
Figure 5. World Glioma Treatment Average Price (2018-2029) & (US$/Unit)
Figure 6. World Glioma Treatment Production Value Market Share by Region (2018-2029)
Figure 7. World Glioma Treatment Production Market Share by Region (2018-2029)
Figure 8. North America Glioma Treatment Production (2018-2029) & (K Units)
Figure 9. Europe Glioma Treatment Production (2018-2029) & (K Units)
Figure 10. China Glioma Treatment Production (2018-2029) & (K Units)
Figure 11. Japan Glioma Treatment Production (2018-2029) & (K Units)
Figure 12. Glioma Treatment Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Glioma Treatment Consumption (2018-2029) & (K Units)
Figure 15. World Glioma Treatment Consumption Market Share by Region (2018-2029)
Figure 16. United States Glioma Treatment Consumption (2018-2029) & (K Units)
Figure 17. China Glioma Treatment Consumption (2018-2029) & (K Units)
Figure 18. Europe Glioma Treatment Consumption (2018-2029) & (K Units)
Figure 19. Japan Glioma Treatment Consumption (2018-2029) & (K Units)
Figure 20. South Korea Glioma Treatment Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Glioma Treatment Consumption (2018-2029) & (K Units)
Figure 22. India Glioma Treatment Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Glioma Treatment by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Glioma Treatment Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Glioma Treatment Markets in 2022
Figure 26. United States VS China: Glioma Treatment Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Glioma Treatment Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Glioma Treatment Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Glioma Treatment Production Market Share 2022
Figure 30. China Based Manufacturers Glioma Treatment Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Glioma Treatment Production Market Share 2022
Figure 32. World Glioma Treatment Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Glioma Treatment Production Value Market Share by Type in 2022
Figure 34. ChemOthersapy
Figure 35. Drugs
Figure 36. World Glioma Treatment Production Market Share by Type (2018-2029)
Figure 37. World Glioma Treatment Production Value Market Share by Type (2018-2029)
Figure 38. World Glioma Treatment Average Price by Type (2018-2029) & (US$/Unit)
Figure 39. World Glioma Treatment Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 40. World Glioma Treatment Production Value Market Share by Application in 2022
Figure 41. Hospitals
Figure 42. Cancer Research Organizations
Figure 43. Diagnostic Centers
Figure 44. Others
Figure 45. World Glioma Treatment Production Market Share by Application (2018-2029)
Figure 46. World Glioma Treatment Production Value Market Share by Application (2018-2029)
Figure 47. World Glioma Treatment Average Price by Application (2018-2029) & (US$/Unit)
Figure 48. Glioma Treatment Industry Chain
Figure 49. Glioma Treatment Procurement Model
Figure 50. Glioma Treatment Sales Model
Figure 51. Glioma Treatment Sales Channels, Direct Sales, and Distribution
Figure 52. Methodology
Figure 53. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
Sun Pharmaceutical Amgen Teva Pharmaceutical Bristol-Myers Squibb Pfizer Merck Eli Lilly F. Hoffmann-La Roche Ltd AbbVie Genentech BioMimetix Cipla Sigma-Aldrich Panacea Biotec Zydus Cadila Takeda Pharmaceuticals Boston Biomedical Ziopharm Oncology Celldex Therapeutics BERG Oncorus Agenus Deciphera Pharmaceuticals Karyopharm Therapeutics
Related Reports
10 Feb 2023
Medical Care
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
